Sequence information
Variant position: 422 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 613 The length of the canonical sequence.
Location on the sequence:
PNVELAKTGGLEIDSDFGGF
R VNAELQARSNIWVAGDAACF
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human PNVELAKTGGLEIDSDFGGFR VNAELQARSNIWVAGDAACF
Mouse PNVELAKTGGLEIDSDFGGFR VNAELQARSNIWVAGDAACF
Rat PNVELAKTGGLEIDSDFGGFR VNAELQARSNIWVAGDAACF
Drosophila PNTDLAGPSRLEVDRSLGGFV VNAELEARRNLYVAGDASCF
Slime mold PNTNVVKSTTLEIDPINGGYV VNPELQARTDLYVAGDVASY
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
102 – 613
Apoptosis-inducing factor 1, mitochondrial
Region
134 – 483
FAD-dependent oxidoreductase
Binding site
438 – 438
FAD
Alternative sequence
44 – 613
Missing. In isoform 6.
Alternative sequence
325 – 613
Missing. In isoform 4.
Mutagenesis
413 – 430
EIDSDFGGFRVNAELQAR -> AIDSDFGGFAVNAELQAA. Disrupts dimerization. Lower efficiency in stabilizing charge-transfer complexes upon coenzyme reduction.
Beta strand
420 – 422
Literature citations
Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder.
Zong L.; Guan J.; Ealy M.; Zhang Q.; Wang D.; Wang H.; Zhao Y.; Shen Z.; Campbell C.A.; Wang F.; Yang J.; Sun W.; Lan L.; Ding D.; Xie L.; Qi Y.; Lou X.; Huang X.; Shi Q.; Chang S.; Xiong W.; Yin Z.; Yu N.; Zhao H.; Wang J.; Wang J.; Salvi R.J.; Petit C.; Smith R.J.; Wang Q.;
J. Med. Genet. 52:523-531(2015)
Cited for: INVOLVEMENT IN DFNX5; VARIANTS DFNX5 ALA-260; PHE-344; ARG-360; GLN-422; TRP-422; CYS-430; GLN-451; VAL-472; LEU-475; MET-498 AND MET-591;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.